Equity
APOTHEEK HASSELTSEPOORT has made a profit without a break since 2007.
APOTHEEK HASSELTSEPOORT has made a profit without a break since 2007.
The accounts state no turnover.
Of this, €1.5m falls due within a year.
Green is investment, beige is depreciation.
Ten of the last ten came late. The 2019 accounts came latest: 98 days after the end of the period.
Higher net result than 91% of companies in retail trade. Sector median €39,909 · 5,060 companies.
The dashed line is the sector median: 0.6% across 40,276 companies (NACE 47, micro).
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 27% of them on solvency, 32% on liquidity, 96% on profitability and 41% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
In July 2024, 2,613 companies had the same profile as APOTHEEK HASSELTSEPOORT has now. Each dot stands for 7 companies, two years later.
That fits the bankruptcy probability of APOTHEEK HASSELTSEPOORT itself: 0.1% within 12 months.
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,613 companies, not a prediction for APOTHEEK HASSELTSEPOORT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Liquidity is insufficient, with a current ratio of 0.87 (0.83 in 2024), below 1. Short-term debt is 87.4% and cash 26.3% of total assets. 89.9% of the assets are financed with debt and provisions.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
The company filed its last 7 accounts on average 39 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
| Company | ||||
|---|---|---|---|---|
| APOTHEEK HASSELTSEPOORT Diest | €1.7m | €894,811 | 10.1% | 0 |
| APOTHEKEN PEETERS Lummen | €1.4m | €666,289 | 63.7% | 0 |
| LINTERPHARMA Linter | €1.6m | €439,466 | 71.3% | 0 |
| APOTHEEK MEES HASSELT Hasselt | €2.1m | €424,326 | -72.5% | 0 |
| APOTHEEK VITA PHARMA Kontich | €1.0m | €569,723 | 20.1% | 0 |
| Pharma2Care Zuienkerke | €1.8m | €795,580 | 88.4% | - |
| Apotheek Verbist Zemst | €2.1m | €583,158 | 51.9% | 0.7 |
These companies have the same main activity as APOTHEEK HASSELTSEPOORT: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1m and €2.1m, founded between 1978 and 1993.
APOTHEEK HASSELTSEPOORT has existed since 1974. In 2007 the gross margin rose from €126,536 to €290,491.
The gross margin has grown every year since 2021.
DYSS holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.